439 related articles for article (PubMed ID: 27097115)
1. Mycobacterium tuberculosis Rv3628 drives Th1-type T cell immunity via TLR2-mediated activation of dendritic cells and displays vaccine potential against the hyper-virulent Beijing K strain.
Kim WS; Kim JS; Cha SB; Kim H; Kwon KW; Kim SJ; Han SJ; Choi SY; Cho SN; Park JH; Shin SJ
Oncotarget; 2016 May; 7(18):24962-82. PubMed ID: 27097115
[TBL] [Abstract][Full Text] [Related]
2.
Kim WS; Jung ID; Kim JS; Kim HM; Kwon KW; Park YM; Shin SJ
Front Cell Infect Microbiol; 2018; 8():95. PubMed ID: 29637049
[No Abstract] [Full Text] [Related]
3.
Su H; Zhang Z; Liu Z; Peng B; Kong C; Wang H; Zhang Z; Xu Y
J Biol Chem; 2018 Jun; 293(26):10287-10302. PubMed ID: 29739853
[TBL] [Abstract][Full Text] [Related]
4. Comparison of immunogenicity and vaccine efficacy between heat-shock proteins, HSP70 and GrpE, in the DnaK operon of Mycobacterium tuberculosis.
Kim WS; Kim JS; Kim HM; Kwon KW; Eum SY; Shin SJ
Sci Rep; 2018 Sep; 8(1):14411. PubMed ID: 30258084
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterium tuberculosis PE27 activates dendritic cells and contributes to Th1-polarized memory immune responses during in vivo infection.
Kim WS; Kim JS; Cha SB; Kim SJ; Kim H; Kwon KW; Han SJ; Choi SY; Shin SJ
Immunobiology; 2016 Mar; 221(3):440-53. PubMed ID: 26655143
[TBL] [Abstract][Full Text] [Related]
6. Vaccine efficacy of a
Kwon KW; Choi HH; Han SJ; Kim JS; Kim WS; Kim H; Kim LH; Kang SM; Park J; Shin SJ
FASEB J; 2019 May; 33(5):6483-6496. PubMed ID: 30753099
[No Abstract] [Full Text] [Related]
7. Mycobacterium tuberculosis RpfE promotes simultaneous Th1- and Th17-type T-cell immunity via TLR4-dependent maturation of dendritic cells.
Choi HG; Kim WS; Back YW; Kim H; Kwon KW; Kim JS; Shin SJ; Kim HJ
Eur J Immunol; 2015 Jul; 45(7):1957-71. PubMed ID: 25907170
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterium tuberculosis PstS1 amplifies IFN-γ and induces IL-17/IL-22 responses by unrelated memory CD4+ T cells via dendritic cell activation.
Palma C; Schiavoni G; Abalsamo L; Mattei F; Piccaro G; Sanchez M; Fernandez C; Singh M; Gabriele L
Eur J Immunol; 2013 Sep; 43(9):2386-97. PubMed ID: 23719937
[TBL] [Abstract][Full Text] [Related]
9. Mycobacterium tuberculosis RpfB drives Th1-type T cell immunity via a TLR4-dependent activation of dendritic cells.
Kim JS; Kim WS; Choi HG; Jang B; Lee K; Park JH; Kim HJ; Cho SN; Shin SJ
J Leukoc Biol; 2013 Oct; 94(4):733-49. PubMed ID: 23825389
[TBL] [Abstract][Full Text] [Related]
10. The ΔfbpA attenuated candidate vaccine from Mycobacterium tuberculosis, H37Rv primes for a stronger T-bet dependent Th1 immunity in mice.
Roche CM; Smith A; Lindsey DR; Meher A; Schluns K; Arora A; Armitige LY; Jagannath C
Tuberculosis (Edinb); 2011 Dec; 91 Suppl 1():S96-104. PubMed ID: 22082615
[TBL] [Abstract][Full Text] [Related]
11. PPE39 of the
Choi HH; Kwon KW; Han SJ; Kang SM; Choi E; Kim A; Cho SN; Shin SJ
J Cell Sci; 2019 Sep; 132(17):. PubMed ID: 31371491
[TBL] [Abstract][Full Text] [Related]
12. Rv0315, a novel immunostimulatory antigen of Mycobacterium tuberculosis, activates dendritic cells and drives Th1 immune responses.
Byun EH; Kim WS; Shin AR; Kim JS; Whang J; Won CJ; Choi Y; Kim SY; Koh WJ; Kim HJ; Shin SJ
J Mol Med (Berl); 2012 Mar; 90(3):285-98. PubMed ID: 21993523
[TBL] [Abstract][Full Text] [Related]
13. Mycobacterium tuberculosis MmsA, a novel immunostimulatory antigen, induces dendritic cell activation and promotes Th1 cell-type immune responses.
Kim JS; Kim WS; Choi HH; Kim HM; Kwon KW; Han SJ; Cha SB; Cho SN; Koh WJ; Shin SJ
Cell Immunol; 2015; 298(1-2):115-25. PubMed ID: 26507911
[TBL] [Abstract][Full Text] [Related]
14. Rv2299c, a novel dendritic cell-activating antigen of Mycobacterium tuberculosis, fused-ESAT-6 subunit vaccine confers improved and durable protection against the hypervirulent strain HN878 in mice.
Choi HG; Choi S; Back YW; Paik S; Park HS; Kim WS; Kim H; Cha SB; Choi CH; Shin SJ; Kim HJ
Oncotarget; 2017 Mar; 8(12):19947-19967. PubMed ID: 28193909
[TBL] [Abstract][Full Text] [Related]
15. Mycobacterium tuberculosis promotes Th17 expansion via regulation of human dendritic cells toward a high CD14 and low IL-12p70 phenotype that reprograms upon exogenous IFN-γ.
Søndergaard JN; Laursen JM; Rosholm LB; Brix S
Int Immunol; 2014 Dec; 26(12):705-16. PubMed ID: 25223368
[TBL] [Abstract][Full Text] [Related]
16. PPE26 induces TLR2-dependent activation of macrophages and drives Th1-type T-cell immunity by triggering the cross-talk of multiple pathways involved in the host response.
Su H; Kong C; Zhu L; Huang Q; Luo L; Wang H; Xu Y
Oncotarget; 2015 Nov; 6(36):38517-37. PubMed ID: 26439698
[TBL] [Abstract][Full Text] [Related]
17. Mycobacterium tuberculosis Rv0577, a novel TLR2 agonist, induces maturation of dendritic cells and drives Th1 immune response.
Byun EH; Kim WS; Kim JS; Jung ID; Park YM; Kim HJ; Cho SN; Shin SJ
FASEB J; 2012 Jun; 26(6):2695-711. PubMed ID: 22415304
[TBL] [Abstract][Full Text] [Related]
18. Early secreted antigen ESAT-6 of Mycobacterium tuberculosis promotes protective T helper 17 cell responses in a toll-like receptor-2-dependent manner.
Chatterjee S; Dwivedi VP; Singh Y; Siddiqui I; Sharma P; Van Kaer L; Chattopadhyay D; Das G
PLoS Pathog; 2011 Nov; 7(11):e1002378. PubMed ID: 22102818
[TBL] [Abstract][Full Text] [Related]
19.
Choi S; Choi HG; Shin KW; Back YW; Park HS; Lee JH; Kim HJ
J Immunol Res; 2018; 2018():3525302. PubMed ID: 29736404
[TBL] [Abstract][Full Text] [Related]
20. Targeting
Velasquez LN; Stüve P; Gentilini MV; Swallow M; Bartel J; Lycke NY; Barkan D; Martina M; Lujan HD; Kalay H; van Kooyk Y; Sparwasser TD; Berod L
Front Immunol; 2018; 9():471. PubMed ID: 29662482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
